Evidence map›Paper›PMID 42500328›Full record

ArticleComputational and structural biotechnology journal2026

Epigenomics-Guided Multi-Omics Integration Uncovers a Lipid-Metabolic Signature with Translational Utility in Bladder Cancer.

Yu-De Wang, Yo-Liang Lai, Chia-Hsin Liu, Yu-Ting Su, Pei-Chun Shen, Fang-Hsin Chen, Chia-Yang Li, Shu-Chi Wang, Wen-Lung Ma, Chi-Ping Huang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yu-De WangDepartment of Urology, China Medical University Hospital, Taichung, Taiwan.ORCID https://orcid.org/0000-0002-0339-5226
Yo-Liang LaiDepartment of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.
Chia-Hsin LiuCancer Biology and Precision Therapeutics Center, China Medical University, Taichung, Taiwan.ORCID https://orcid.org/0000-0002-2880-8365
Yu-Ting SuGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Pei-Chun ShenCancer Biology and Precision Therapeutics Center, China Medical University, Taichung, Taiwan.ORCID https://orcid.org/0009-0001-0733-5706
Fang-Hsin ChenInstitute of Nuclear Engineering and Science, National Tsing Hua University, Hsinchu, Taiwan.ORCID https://orcid.org/0000-0002-1671-4863
Chia-Yang LiGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0001-5689-9850
Shu-Chi WangDepartment of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0001-9691-7507
Wen-Lung MaGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.ORCID https://orcid.org/0009-0002-7116-4304
Chi-Ping HuangDepartment of Urology, China Medical University Hospital, Taichung, Taiwan.
Wei-Chung ChengGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.ORCID https://orcid.org/0000-0002-1229-4857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42500328
PMCPMC13396492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.